186 related articles for article (PubMed ID: 12107982)
21. Relationship of coagulation test abnormalities to tumour burden and postoperative DVT in resected colorectal cancer.
Iversen LH; Thorlacius-Ussing O
Thromb Haemost; 2002 Mar; 87(3):402-8. PubMed ID: 11916070
[TBL] [Abstract][Full Text] [Related]
22. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
23. [Incidence of deep venous thrombosis (DVT) in patients undergoing thoracotomy and changes of hemostasis].
Yuan XZ; Wu XM; Chen M; Yuan JY; Zhang SS
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):529-32. PubMed ID: 15489937
[TBL] [Abstract][Full Text] [Related]
24. Evaluating prethrombotic state in lung cancer using molecular markers.
Gabazza EC; Taguchi O; Yamakami T; Machishi M; Ibata H; Suzuki S
Chest; 1993 Jan; 103(1):196-200. PubMed ID: 7678080
[TBL] [Abstract][Full Text] [Related]
25. Contribution of D-Dimer determination in the exclusion of deep venous thrombosis in spinal cord injury patients.
Roussi J; Bentolila S; Boudaoud L; Casadevall N; Vallée C; Carlier R; Lortat-Jacob S; Dizien O; Bussel B
Spinal Cord; 1999 Aug; 37(8):548-52. PubMed ID: 10455530
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic significance of thrombin-antithrombin III complex (TAT) and D-dimer in patients with deep venous thrombosis.
Sassa H; Sone T; Tsuboi H; Kondo J; Yabashi T
Jpn Circ J; 1996 Apr; 60(4):201-6. PubMed ID: 8726168
[TBL] [Abstract][Full Text] [Related]
27. Coagulation and fibrinolysis markers and risk of dementia. The Dutch Vascular Factors in Dementia Study.
Bots ML; Breteler MM; van Kooten F; Haverkate F; Meijer P; Koudstaal PJ; Grobbee DE; Kluft C
Haemostasis; 1998; 28(3-4):216-22. PubMed ID: 10420069
[TBL] [Abstract][Full Text] [Related]
28. [Activation of hemostasis in patients with chronic cholecystitis].
Kłoczko J; Lewandowski JJ; Galar M; Mazgajska-Barczyk K; Panek M
Pol Merkur Lekarski; 2001 Jan; 10(55):19-20. PubMed ID: 11320544
[TBL] [Abstract][Full Text] [Related]
29. Dose-adjusted thrombosis prophylaxis in trauma surgery according to levels of D-Dimer.
Peetz D; Hafner G; Hansen M; Mayer A; Rippin G; Rommens PM; Prellwitz W
Thromb Res; 2000 Jun; 98(6):473-83. PubMed ID: 10899346
[TBL] [Abstract][Full Text] [Related]
30. The clinical usefulness of D-dimer testing in cancer patients with suspected deep venous thrombosis.
ten Wolde M; Kraaijenhagen RA; Prins MH; Büller HR
Arch Intern Med; 2002 Sep; 162(16):1880-4. PubMed ID: 12196087
[TBL] [Abstract][Full Text] [Related]
31. D-dimer screening for deep venous thrombosis in traumatic cervical spinal injuries.
Masuda M; Ueta T; Shiba K; Iwamoto Y
Spine J; 2015 Nov; 15(11):2338-44. PubMed ID: 26130085
[TBL] [Abstract][Full Text] [Related]
32. Alterations of haemostatic markers in various subtypes and phases of stroke.
Yamazaki M; Uchiyama S; Maruyama S
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):707-12. PubMed ID: 7507362
[TBL] [Abstract][Full Text] [Related]
33. Thrombosis markers in hip versus knee arthroplasty: a pilot study.
Reikeras O; Clementsen T
J Orthop Surg (Hong Kong); 2009 Dec; 17(3):291-5. PubMed ID: 20065366
[TBL] [Abstract][Full Text] [Related]
34. D-dimer and TAT measurement in patients with deep venous thrombosis: utility in diagnosis and judgement of anticoagulant treatment effectiveness.
Speiser W; Mallek R; Koppensteiner R; Stümpflen A; Kapiotis S; Minar E; Ehringer H; Lechner K
Thromb Haemost; 1990 Oct; 64(2):196-201. PubMed ID: 2125371
[TBL] [Abstract][Full Text] [Related]
35. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
[TBL] [Abstract][Full Text] [Related]
36. Hemostasis in newborns of smoking and nonsmoking mothers.
Mercelina-Roumans PE; Ubachs JM; van Wersch JW
Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
[TBL] [Abstract][Full Text] [Related]
37. Hemostatic activation in spontaneous intracerebral hemorrhage.
Fujii Y; Takeuchi S; Harada A; Abe H; Sasaki O; Tanaka R
Stroke; 2001 Apr; 32(4):883-90. PubMed ID: 11283387
[TBL] [Abstract][Full Text] [Related]
38. Establishing the Transient Mass Balance of Thrombosis: From Tissue Factor to Thrombin to Fibrin Under Venous Flow.
Zhu S; Chen J; Diamond SL
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1528-1536. PubMed ID: 29724819
[TBL] [Abstract][Full Text] [Related]
39. Problems with assessing the value of D-dimer for excluding deep vein thrombosis.
Egermayer P
N Z Med J; 2001 May; 114(1131):216. PubMed ID: 11421439
[No Abstract] [Full Text] [Related]
40. Effects of warfarin on markers of hypercoagulability in patients with heart failure.
Jafri SM; Mammen EF; Masura J; Goldstein S
Am Heart J; 1997 Jul; 134(1):27-36. PubMed ID: 9266780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
